204 related articles for article (PubMed ID: 20832033)
1. [Transurethral needle ablation Prostiva for treating symptomatic benign prostatic hyperplasia: a review].
Xylinas E; Le Gal S; Descazeaud A
Prog Urol; 2010 Sep; 20(8):566-71. PubMed ID: 20832033
[TBL] [Abstract][Full Text] [Related]
2. A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period.
Naslund MJ; Carlson AM; Williams MJ
J Urol; 2005 Jun; 173(6):2090-3; discussion 2093. PubMed ID: 15879849
[TBL] [Abstract][Full Text] [Related]
3. Transurethral needle ablation (TUNA): histopathological, radiological and clinical studies of a new office procedure for treatment of benign prostatic hyperplasia.
Schulman CC; Zlotta AR
Prog Clin Biol Res; 1994; 386():479-86. PubMed ID: 7528418
[TBL] [Abstract][Full Text] [Related]
4. [Advances in minimally invasive treatment of benign prostatic hyperplasia].
Yu B; Wang Z
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):739-43. PubMed ID: 17918717
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia.
Boyle P; Robertson C; Vaughan ED; Fitzpatrick JM
BJU Int; 2004 Jul; 94(1):83-8. PubMed ID: 15217437
[TBL] [Abstract][Full Text] [Related]
6. Transurethral needle ablation (TUNA): histopathological, radiological and clinical studies of a new office procedure for treatment of benign prostatic hyperplasia.
Hourriez LA; Zlotta AR; Schulman CC
Acta Urol Belg; 1994 Dec; 62(4):33-8. PubMed ID: 7540796
[TBL] [Abstract][Full Text] [Related]
7. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
Rosario DJ; Phillips JT; Chapple CR
J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
[TBL] [Abstract][Full Text] [Related]
8. [Transurethral ablation (Precision Plus) in the treatment of patients with benign prostatic hyperplasia].
Mazo EB; Krivoborodov GG
Urologiia; 2005; (3):12-5. PubMed ID: 16097706
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive therapies for benign prostatic hyperplasia.
Tunuguntla HS; Evans CP
World J Urol; 2002 Sep; 20(4):197-206. PubMed ID: 12215846
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
[TBL] [Abstract][Full Text] [Related]
11. Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature.
Djavan B; Eckersberger E; Handl MJ; Brandner R; Sadri H; Lepor H
Can J Urol; 2010 Aug; 17(4):5249-54. PubMed ID: 20735902
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of benign prostatic hyperplasia (BPH) by transurethral needle ablation (TUNA) and 36-month follow-up of the retreatment rate].
Martin X; Claude A; Colombel M; Sarramon JP; Ballanger P; Lobel B; Richard F; Saussine C; Cavillon C; Buzelin JM; Baron JC; Lambert D; Haillot O
Prog Urol; 2005 Sep; 15(4):674-80. PubMed ID: 16459684
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia.
Bouza C; López T; Magro A; Navalpotro L; Amate JM
BMC Urol; 2006 Jun; 6():14. PubMed ID: 16790044
[TBL] [Abstract][Full Text] [Related]
14. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience.
Kahn SA; Alphonse P; Tewari A; Narayan P
J Urol; 1998 Nov; 160(5):1695-700. PubMed ID: 9783934
[TBL] [Abstract][Full Text] [Related]
15. Transurethral needle ablation of the prostate (TUNA): pathological, radiological and clinical study of a new office procedure for treatment of benign prostatic hyperplasia using low-level radiofrequency energy.
Schulman C; Zlotta A
Arch Esp Urol; 1994 Nov; 47(9):895-901. PubMed ID: 7530946
[TBL] [Abstract][Full Text] [Related]
16. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study.
Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC
J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive surgery in the management of benign prostatic hyperplasia.
Berardinelli F; Hinh P; Wang R
Minerva Urol Nefrol; 2009 Sep; 61(3):269-89. PubMed ID: 19773728
[TBL] [Abstract][Full Text] [Related]
18. Treatment options for benign prostatic hyperplasia in older men.
Miano R; De Nunzio C; Asimakopoulos AD; Germani S; Tubaro A
Med Sci Monit; 2008 Jul; 14(7):RA94-102. PubMed ID: 18591930
[TBL] [Abstract][Full Text] [Related]
19. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.
Roehrborn CG; Burkhard FC; Bruskewitz RC; Issa MM; Perez-Marrero R; Naslund MJ; Shumaker BP
J Urol; 1999 Jul; 162(1):92-7. PubMed ID: 10379748
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of benign prostatic hyperplasia by radiofrequency (TUNA): a monocentric study of 28 cases treated in ambulatory surgery].
Le Gal S; Fouques Y; Mallick S; Taksin L; Le Toquin-Bernard S; Frachet O; Bensadoun H
Prog Urol; 2009 May; 19(5):327-32. PubMed ID: 19393538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
